GLOBALT Investments LLC / GA 13F: Cuts IBM Stake by $3.5M

On October 27, 2026, GLOBALT Investments LLC cut its stake in International Business Machines Corporation (IBM) by 15,925 shares, bringing its total to 1,514 shares. This reduction in position is valued at approximately $3,329,740. The information comes from the fund's latest Form 13F filing with the SEC.

IBM International Business Machines Corporation

$250.06 ▼ -12.47% year to date

1M 3M YTD

Daily close · Oct 27, 2026

Where IBM Fits in GLOBALT Investments' Portfolio

IBM now accounts for 0.02% of GLOBALT's total reported value of about $1.68 billion. The fund ranks 47th in its portfolio, with this cut representing a 91.3% decrease in its IBM position.

International Business Machines Corporation Stock Down 1.3%

IBM's stock recently trades around $250.24, which is about equal to its closing price of $250.25 on October 27, 2026. The stock is currently above its 50-day moving average by about 7.2%, but it is below its 52-week high by 24.7%.

Recent Earnings

In its latest financial report, IBM posted trailing twelve-month revenue of approximately $69.87 billion. The company reported an earnings per share (EPS) of $11.72, reflecting a solid performance amid ongoing market challenges. The next earnings report is expected on January 27, 2027.

Dividend

IBM pays an annual dividend rate of $6.76 per share, translating to a yield of 2.67%. The company's dividend payout ratio stands at 57.5%, indicating a stable return to shareholders.

Insider Buying and Selling at International Business Machines Corporation

Several insiders have recently traded shares of IBM. David N. Farr, a Director, bought 1,000 shares at $304.00 on January 30, 2026. Similarly, Michelle J. Howard and Michael Miebach, both Directors, purchased 50 and 434 shares, respectively, at prices of $237.83 and $233.33 on February 25, 2026. On the other hand, Robert David Thomas, an Officer, sold 25,000 shares at $230.32 on August 26, 2026.

Analysts Set New Price Targets

On October 22, 2026, Jefferies maintained a Buy rating on IBM with a price target of $280.00, while Citigroup also kept a Buy rating with a target of $280.00. UBS maintained a Neutral rating with a target of $243.00. Overall, analysts have a consensus recommendation of Buy with a mean price target of $257.22.

About IBM

International Business Machines Corporation, commonly known as IBM, is a technology company that provides integrated solutions and services. It operates in multiple segments, including Software, Consulting, Infrastructure, and Financing. IBM's focus on hybrid cloud and AI platforms positions it well for future growth.

Bottom Line

Investors should keep an eye on IBM's upcoming earnings report on January 27, 2027, as well as any further filings from GLOBALT Investments. The recent reduction in its stake may signal a shift in the fund's strategy regarding this technology giant.